Formic Acid

Formic Acid

SCHEMBL27975005

COCC1CCCN1CCN.O=CO

nearest known ligand 0.46

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ARG1 P05089 2/20 0.46
ARG2 P78540 2/20 0.46
HDAC8 Q9BY41 2/20 0.42
HDAC6 Q9UBN7 2/20 0.42
HDAC1 Q13547 1/20 0.42
HRH3 Q9Y5N1 2/20 0.42
FPR3 P25089 1/20 0.40
FPR2 P25090 1/20 0.40
DRD2 P14416 2/20 0.39
HTR2A P28223 2/20 0.39
HTR2C P28335 2/20 0.39
VEGFA P15692 1/20 0.37
EGLN1 Q9GZT9 1/20 0.37
PNP P00491 1/20 0.37
TLR7 Q9NYK1 1/20 0.35
KCNH2 Q12809 1/20 0.34
MCHR2 Q969V1 1/20 0.34
MCHR1 Q99705 1/20 0.34
SMYD3 Q9H7B4 1/20 0.34
CASP3 P42574 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10064193 0.91 ARG1 (0.46) ARG1ARG2HDAC8HDAC6HDAC1
SCHEMBL2826704 0.91 ARG1 (0.46) ARG1ARG2HDAC8HDAC6HDAC1
SCHEMBL2826706 0.91 ARG1 (0.46) ARG1ARG2HDAC8HDAC6HDAC1
Formic Acid SCHEMBL28136600 0.81 ARG1 (0.30) ARG1ARG2
SCHEMBL7309724 0.81 ARG1 (0.47) ARG1ARG2HDAC8HDAC6HDAC1
SCHEMBL7309716 0.81 ARG1 (0.47) ARG1ARG2HDAC8HDAC6HDAC1
SCHEMBL12280378 0.81 ARG1 (0.47) ARG1ARG2HDAC8HDAC6HDAC1
SCHEMBL855183 0.80 ARG1 (0.46) ARG1ARG2HDAC8HDAC6HDAC1
SCHEMBL2826721 0.78 ARG1 (0.45) ARG1ARG2HDAC8HDAC6HDAC1
SCHEMBL24917581 0.77 DRD2 (0.46) ARG1ARG2HDAC8HDAC6HDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105001218-A Bicyclic heterocycle derivatives for the treatment of pulmonary arterial hypertension NOVARTIS AG 2015-10-28 CN disclosed
CN-104024252-B Bicyclic heterocyclic derivatives for the treatment of pulmonary hypertension NOVARTIS AG (CH) 2015-08-26 CN disclosed
CN-104024252-A Bicyclic heterocyclic derivatives for the treatment of pulmonary hypertension NOVARTIS AG 2014-09-03 CN disclosed